Found 638 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is L  [Clear All Filters]
2019
Moda-Sava RN, Murdock MH, Parekh PK, Fetcho RN, Huang BS, Huynh TN, Witztum J, Shaver DC, Rosenthal DL, Alway EJ et al..  2019.  Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation.. Science. 364(6436)
Thibaut A, Schiff N, Giacino J, Laureys S, Gosseries O.  2019.  Therapeutic interventions in patients with prolonged disorders of consciousness.. Lancet Neurol.
Sanz LRD, Lejeune N, Blandiaux S, Bonin E, Thibaut A, Stender J, Farber NM, Zafonte RD, Schiff ND, Laureys S et al..  2019.  Treating Disorders of Consciousness With Apomorphine: Protocol for a Double-Blind Randomized Controlled Trial Using Multimodal Assessments.. Front Neurol. 10:248.
Sanz LRD, Lejeune N, Blandiaux S, Bonin E, Thibaut A, Stender J, Farber NM, Zafonte RD, Schiff ND, Laureys S et al..  2019.  Treating Disorders of Consciousness With Apomorphine: Protocol for a Double-Blind Randomized Controlled Trial Using Multimodal Assessments.. Front Neurol. 10:248.
Notaras M, Allen M, Longo F, Volk N, Toth M, Jeon NLi, Klann E, Colak D.  2019.  UPF2 leads to degradation of dendritically targeted mRNAs to regulate synaptic plasticity and cognitive function.. Mol Psychiatry.
Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, Harrington MG, Pa J, Law M, Wang DJJ et al..  2019.  Vascular dysfunction-The disregarded partner of Alzheimer's disease.. Alzheimers Dement. 15(1):158-167.
Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, Harrington MG, Pa J, Law M, Wang DJJ et al..  2019.  Vascular dysfunction-The disregarded partner of Alzheimer's disease.. Alzheimers Dement. 15(1):158-167.
Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, Harrington MG, Pa J, Law M, Wang DJJ et al..  2019.  Vascular dysfunction-The disregarded partner of Alzheimer's disease.. Alzheimers Dement. 15(1):158-167.
Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, Harrington MG, Pa J, Law M, Wang DJJ et al..  2019.  Vascular dysfunction-The disregarded partner of Alzheimer's disease.. Alzheimers Dement. 15(1):158-167.
Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, Harrington MG, Pa J, Law M, Wang DJJ et al..  2019.  Vascular dysfunction-The disregarded partner of Alzheimer's disease.. Alzheimers Dement. 15(1):158-167.
2018
Ranea-Robles P, Launay N, Ruiz M, Calingasan NYlagan, Dumont M, Naudí A, Portero-Otín M, Pamplona R, Ferrer I, M Beal F et al..  2018.  Aberrant regulation of the GSK-3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy.. EMBO Mol Med.
Brea D, Poon C, Murphy M, Lubitz G, Iadecola C, Anrather J.  2018.  Ablation of nasal-associated lymphoid tissue does not affect focal ischemic brain injury in mice.. PLoS One. 13(10):e0205470.
Intlekofer AM, Shih AH, Wang B, Nazir A, Rustenburg AS, Albanese SK, Patel M, Famulare C, Correa FM, Takemoto N et al..  2018.  Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations.. Nature.
Intlekofer AM, Shih AH, Wang B, Nazir A, Rustenburg AS, Albanese SK, Patel M, Famulare C, Correa FM, Takemoto N et al..  2018.  Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations.. Nature.
Gaisina IN, Lee SH, Kaidery NA, Ben Aissa M, Ahuja M, Smirnova NN, Wakade S, Gaisin A, Bourassa MW, Ratan RR et al..  2018.  Activation of Nrf2 and Hypoxic Adaptive Response Contribute to Neuroprotection Elicited by Phenylhydroxamic Acid Selective HDAC6 Inhibitors.. ACS Chem Neurosci.
Kamel H, Longstreth WT, Tirschwell DL, Kronmal RA, Broderick JP, Palesch YY, Meinzer C, Dillon C, Ewing I, Spilker JA et al..  2018.  The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods.. Int J Stroke. :1747493018799981.
Kamel H, Bartz TM, Elkind MSV, Okin PM, Thacker EL, Patton KK, Stein PK, deFilippi CR, Gottesman RF, Heckbert SR et al..  2018.  Atrial Cardiopathy and the Risk of Ischemic Stroke in the CHS (Cardiovascular Health Study).. Stroke.
Giza JI, Kim J, Meyer HC, Anastasia A, Dincheva I, Zheng CI, Lopez K, Bains H, Yang J, Bracken C et al..  2018.  The BDNF Val66Met Prodomain Disassembles Dendritic Spines Altering Fear Extinction Circuitry and Behavior.. Neuron. 99(1):163-178.e6.
Giza JI, Kim J, Meyer HC, Anastasia A, Dincheva I, Zheng CI, Lopez K, Bains H, Yang J, Bracken C et al..  2018.  The BDNF Val66Met Prodomain Disassembles Dendritic Spines Altering Fear Extinction Circuitry and Behavior.. Neuron. 99(1):163-178.e6.
Giza JI, Kim J, Meyer HC, Anastasia A, Dincheva I, Zheng CI, Lopez K, Bains H, Yang J, Bracken C et al..  2018.  The BDNF Val66Met Prodomain Disassembles Dendritic Spines Altering Fear Extinction Circuitry and Behavior.. Neuron. 99(1):163-178.e6.
Omran SS, Lerario MP, Gialdini G, Merkler AE, Moya A, Chen ML, Kamel H, DeSancho M, Navi BB.  2018.  Clinical Impact of Thrombophilia Screening in Young Adults with Ischemic Stroke.. J Stroke Cerebrovasc Dis.
Kummer BR, Lerario MP, Navi BB, Ganzman AC, Ribaudo D, Mir SA, Pishanidar S, Lekic T, Williams O, Kamel H et al..  2018.  Clinical Information Systems Integration in New York City's First Mobile Stroke Unit.. Appl Clin Inform. 9(1):89-98.
Kummer BR, Lerario MP, Navi BB, Ganzman AC, Ribaudo D, Mir SA, Pishanidar S, Lekic T, Williams O, Kamel H et al..  2018.  Clinical Information Systems Integration in New York City's First Mobile Stroke Unit.. Appl Clin Inform. 9(1):89-98.
Gan L, Cookson MR, Petrucelli L, La Spada AR.  2018.  Converging pathways in neurodegeneration, from genetics to mechanisms.. Nat Neurosci. 21(10):1300-1309.
Kim S-E, Lei Y, Hwang S-H, Wlodarczyk BJ, Mukhopadhyay S, Shaw GM, M Ross E, Finnell RH.  2018.  Dominant negative GPR161 rare variants are risk factors of human spina bifida.. Hum Mol Genet.